Stable Isotope Labelled Clivatuzumab Biosimilar – Anti-MUC1/CD227 mAb – Research Grade

Reference: PX-TA1390-SIL-1MG
Size

Brand

Product type

Clonality

Expression system

Applications

Product nameStable Isotope Labelled Clivatuzumab Biosimilar - Anti-MUC1/CD227 mAb - Research Grade
SourceCAS 1462876-11-4
SpeciesHumanized
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 5-8 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsMS
Aliases /SynonymshPAM4,hPAM4 IgG-DOTA,hPAM4-DOTA
ReferencePX-TA1390-SIL
Related ProductsPX-P4727
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
FormatLyophilized
LabellingArginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99%
Isotopic Enrichment99%
Stability1 year

Description of Stable Isotope Labelled Clivatuzumab Biosimilar - Anti-MUC1/CD227 mAb - Research Grade

General information on Anti-MUC1/CD227[Homo sapiens] (Clivatuzumab) Monoclonal Antibody

Clivatuzumab is investigated for the treatment of Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Stable Isotope Labelled Clivatuzumab Biosimilar – Anti-MUC1/CD227 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products